Marshall Fordyce

Marshall Fordyce

Oprichter bij VERA THERAPEUTICS, INC.

Vermogen: 9 M $ op 30-04-2024

50 jaar
Health Technology
Consumer Services

Oorsprong van het eerstegraads netwerk van Marshall Fordyce

EntiteitType entiteitIndustrie
Public Company Biotechnology 23
Albert & Mary Lasker Foundation
7
Private Company 7

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Marshall Fordyce via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
AMGEN INC. Pharmaceuticals: Major

Beth Seidenberg

Robert M. Brenner

Brian Kotzin

Celia Lin

Private Equity Investor

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

BECTON, DICKINSON AND COMPANY Medical Specialties

Christopher Jones

Willard Overlock

Alfred Sommer

Claire Pomeroy

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

GILEAD SCIENCES, INC. Biotechnology

Andrew Cheng

Chief Tech/Sci/R&D Officer

Biotechnology

William D. Turner

General Counsel

Miscellaneous Commercial Services

Scott Morrison

Joseph Young

Corporate Officer/Principal

Comptroller/Controller/Auditor

Lasker Foundation

Willard Overlock

Alfred Sommer

Anthony Evnin

Claire Pomeroy

Director/Board Member

Director/Board Member

Director/Board Member

President

University of California, Los Angeles College/University

Allen Ebens

Joseph Young

Celia Lin

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

The Johns Hopkins University College/University

Alfred Sommer

Robert M. Brenner

Andrew Cheng

Graduate Degree

Undergraduate Degree

Undergraduate Degree

The Rockefeller University College/University

Willard Overlock

Anthony Evnin

Director/Board Member

Director/Board Member

Johns Hopkins Bloomberg School of Public Health College/University

Christopher Jones

Alfred Sommer

Corporate Officer/Principal

Corporate Officer/Principal

ACCELERON PHARMA INC. Biotechnology

Anthony Evnin

Kurt von Emster

Director/Board Member

Corporate Officer/Principal

AIMMUNE THERAPEUTICS, INC. Pharmaceuticals: Major

Patrick Enright

William D. Turner

Director/Board Member

Corporate Officer/Principal

Haas School of Business College/University

Scott Morrison

Joseph Young

Undergraduate Degree

Masters Business Admin

Miscellaneous Commercial Services

Alfred Sommer

Claire Pomeroy

Corporate Officer/Principal

Corporate Officer/Principal

VAXCYTE, INC. Biotechnology

Patrick Enright

Kurt von Emster

Director/Board Member

Chairman

Princeton University College/University

Anthony Evnin

Lauren Frenz

Director/Board Member

Undergraduate Degree

Pharmaceuticals: Major

Patrick Enright

Kurt von Emster

Director/Board Member

Director/Board Member

KYVERNA THERAPEUTICS, INC. Biotechnology

Beth Seidenberg

Brian Kotzin

Director/Board Member

Director/Board Member

CYMABAY THERAPEUTICS, INC. Biotechnology

Anthony Evnin

Kurt von Emster

Director/Board Member

Director/Board Member

Harvard Medical School College/University

Alfred Sommer

Catherine McCormick Blair

Doctorate Degree

Corporate Officer/Principal

Stanford University College/University

Patrick Enright

Julien Capers

Undergraduate Degree

Undergraduate Degree

College/University

James Fordyce

Michael Morrissey

Masters Business Admin

Doctorate Degree

Harvard T.H. Chan School of Public Health College/University

Catherine McCormick Blair

Corporate Officer/Principal

Investment Managers

Maha Katabi

Chief Investment Officer

Miscellaneous Commercial Services

Catherine McCormick Blair

Director/Board Member

RAYZEBIO, INC. Biotechnology

Maha Katabi

Director/Board Member

Ascendis Pharma, Inc.

Maha Katabi

Director/Board Member

Biotechnology

Maha Katabi

Director/Board Member

Miscellaneous Commercial Services

Catherine McCormick Blair

Director/Board Member

College/University

Catherine McCormick Blair

Director/Board Member

Investment Trusts/Mutual Funds

Catherine McCormick Blair

Corporate Officer/Principal

CODIAK BIOSCIENCES Pharmaceuticals: Major

Robert M. Brenner

Chief Tech/Sci/R&D Officer

MORPHOSYS AG Biotechnology

Andrew Cheng

Director/Board Member

Columbia University College of Physicians & Surgeons College/University

Andrew Cheng

Doctorate Degree

ARBUTUS BIOPHARMA CORPORATION Pharmaceuticals: Major

Andrew Cheng

Director/Board Member

AKERO THERAPEUTICS, INC. Pharmaceuticals: Major

Andrew Cheng

Chief Executive Officer

Biotechnology

Andrew Cheng

Director/Board Member

Miscellaneous Commercial Services

Andrew Cheng

Director/Board Member

Packaged Software

Robert M. Brenner

Chief Tech/Sci/R&D Officer

DYNAVAX TECHNOLOGIES CORPORATION Biotechnology

William D. Turner

General Counsel

Biotechnology

Robert M. Brenner

Chief Executive Officer

Albert Einstein College of Medicine, Inc. College/University

Robert M. Brenner

Doctorate Degree

AMAG PHARMACEUTICALS, INC. Pharmaceuticals: Major

Robert M. Brenner

Chief Tech/Sci/R&D Officer

Biotechnology

Maha Katabi

Director/Board Member

The California State University College/University

William D. Turner

Undergraduate Degree

Statistieken

Internationaal

Verenigde Staten 44
Canada 3
Bermuda 2
Duitsland 2

Sectoraal

Health Technology 24
Consumer Services 15
Commercial Services 6
Finance 2
Miscellaneous 2

Operationeel

Director/Board Member 217
Corporate Officer/Principal 67
Independent Dir/Board Member 57
Undergraduate Degree 27
Chairman 22